<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/24/brokerages-expect-erie-indemnity-nasdaqerie-to-post-1-31-eps.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-24T13:12:28+00:00"/>
    <meta property="og:title" content="Brokerages Expect Erie Indemnity (NASDAQ:ERIE) to Post $1.31 EPS"/>
    <meta property="og:description" content="Erie Indemnity (NASDAQ:ERIE) has received a consensus broker rating score of 2.00 (Buy) from the two analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and one has issued a strong buy recommendation on the company. Erie Indemnity’s rating score has declined by 100% […]"/>
  </head>
  <body>
    <article>
      <h1>Brokerages Expect Erie Indemnity (NASDAQ:ERIE) to Post $1.31 EPS</h1>
      <address><time datetime="2019-11-24T13:12:28+00:00">24 Nov 2019, 13:12</time> by <a rel="author" href="https://www.thecerbatgem.com/author/renee" target="_blank">Renee Jackson</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/erie-indemnity-company-logo.jpg"/>
      </figure>
      <p>Erie Indemnity (NASDAQ:ERIE) has received a consensus broker rating score of 2.00 (Buy) from the two analysts that cover the company, <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> reports. One research analyst has rated the stock with a hold recommendation and one has issued a strong buy recommendation on the company. Erie Indemnity’s rating score has declined by 100% in the last 90 days as a result of a number of analysts’ upgrades and downgrades.</p>
      <p>Zacks has also assigned Erie Indemnity an industry rank of 60 out of 255 based on the ratings given to related companies.</p>
      <p>A number of equities research analysts have recently commented on ERIE shares. <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> raised shares of Erie Indemnity from a “hold” rating to a “buy” rating and set a $209.00 price objective on the stock in a research note on Thursday, October 31st. <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=ERIE">ValuEngine</a> cut shares of Erie Indemnity from a “hold” rating to a “sell” rating in a research note on Thursday. Finally, BidaskClub cut shares of Erie Indemnity from a “hold” rating to a “sell” rating in a research note on Saturday, October 26th.</p>
      <p>In related news, Director J Ralph Borneman, Jr. sold 20,000 shares of Erie Indemnity stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $210.00, for a total value of $4,200,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at <a href="https://www.sec.gov/Archives/edgar/data/922621/000112760219028721/xslF345X03/form4.xml">this link</a>. 46.87% of the stock is currently owned by company insiders.</p>
      <p>Institutional investors have recently added to or reduced their stakes in the stock. CSat Investment Advisory L.P. acquired a new stake in Erie Indemnity in the 2nd quarter valued at $25,000. Krane Funds Advisors LLC acquired a new stake in Erie Indemnity in the 2nd quarter valued at $26,000. Tower Research Capital LLC TRC acquired a new stake in Erie Indemnity in the 3rd quarter valued at $61,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in Erie Indemnity in the 2nd quarter valued at $76,000. Finally, Assetmark Inc. acquired a new stake in Erie Indemnity in the 2nd quarter valued at $79,000. 35.35% of the stock is currently owned by hedge funds and other institutional investors.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NASDAQ/ERIE/price-target/">Erie Indemnity stock</a> traded up $2.19 during midday trading on Tuesday, hitting $173.21. The company had a trading volume of 105,100 shares, compared to its average volume of 104,612. The stock has a market cap of $7.90 billion, a price-to-earnings ratio of 31.44 and a beta of 0.43. Erie Indemnity has a 12-month low of $123.94 and a 12-month high of $270.23. The company has a fifty day simple moving average of $181.99 and a 200 day simple moving average of $214.07. The company has a quick ratio of 2.10, a current ratio of 2.10 and a debt-to-equity ratio of 0.09.</p>
      <p>Erie Indemnity (NASDAQ:ERIE) last issued its quarterly earnings data on Thursday, October 24th. The financial services provider reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.12. The business had revenue of $638.74 million for the quarter, compared to analysts’ expectations of $639.70 million. Erie Indemnity had a net margin of 13.01% and a return on equity of 30.65%. As a group, analysts expect that Erie Indemnity will post 6.22 EPS for the current year.</p>
      <p>
        <b>About Erie Indemnity</b>
      </p>
      <p>Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, and policy issuance services for the policyholders on behalf of the Erie Insurance Exchange. Its sales related services include agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing, as well as provides administrative support, information technology, and customer services.</p>
      <p>Read More: <a href="https://www.marketbeat.com/financial-terms/growth-stocks-what-they-are/">How to Invest in Growth Stocks</a></p>
      <p>
        <a href="https://www.zacks.com/registration/pfp/?ALERT=ZER_LINK&amp;ADID=AMERBMN_CONTENT_ZER&amp;skip_rpt_name_check=skip_rpt_name_check&amp;t=ERIE">Get a free copy of the Zacks research report on Erie Indemnity (ERIE)</a>
      </p>
      <p>For more information about research offerings from Zacks Investment Research, visit <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks.com</a></p>
    </article>
  </body>
</html>